×
Entrez Id:
5743
Gene Symbol:
PTGS2
PTGS2
Mammary Neoplasms
0.400
AlteredExpression
LHGDN
[Clinicopathologic significance of cyclooxygenase-2 mRNA expression in human breast carcinoma].
12667327
2002
×
Entrez Id:
5743
Gene Symbol:
PTGS2
PTGS2
Mammary Neoplasms
0.400
AlteredExpression
LHGDN
The clear relationship between HER-2/neu status and COX-2 expression in human breast tumors suggests that this mechanism is likely to be operative in vivo.
11901151
2002
×
Entrez Id:
5743
Gene Symbol:
PTGS2
PTGS2
Mammary Neoplasms
0.400
AlteredExpression
LHGDN
Correlation of COX-2 and Ep-CAM overexpression in human invasive breast cancer and its impact on survival.
12592372
2003
×
Entrez Id:
5743
Gene Symbol:
PTGS2
PTGS2
Mammary Neoplasms
0.400
AlteredExpression
LHGDN
Overexpression of cyclooxygenase-2 is associated with breast carcinoma and its poor prognostic factors.
14681319
2003
×
Entrez Id:
5743
Gene Symbol:
PTGS2
PTGS2
Mammary Neoplasms
0.400
AlteredExpression
LHGDN
Histologically normal human mammary epithelia with silenced p16(INK4a) overexpress COX-2, promoting a premalignant program.
15050918
2004
×
Entrez Id:
5743
Gene Symbol:
PTGS2
PTGS2
Mammary Neoplasms
0.400
Biomarker
LHGDN
Role of COX-2, VEGF and cyclin D1 in mammary infiltrating duct carcinoma.
12883688
2004
×
Entrez Id:
5743
Gene Symbol:
PTGS2
PTGS2
Mammary Neoplasms
0.400
AlteredExpression
LHGDN
Expression of the ELAV-like protein HuR is associated with higher tumor grade and increased cyclooxygenase-2 expression in human breast carcinoma.
15328200
2004
×
Entrez Id:
5743
Gene Symbol:
PTGS2
PTGS2
Mammary Neoplasms
0.400
AlteredExpression
LHGDN
Elevated cyclooxygenase-2 expression correlates with distant metastases in breast cancer.
15330183
2004
×
Entrez Id:
5743
Gene Symbol:
PTGS2
PTGS2
Mammary Neoplasms
0.400
AlteredExpression
LHGDN
COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ.
14735188
2004
×
Entrez Id:
5743
Gene Symbol:
PTGS2
PTGS2
Mammary Neoplasms
0.400
AlteredExpression
LHGDN
COX-2 may be directly involved with mammary carcinogenesis, since expression of COX-2 is sufficient for formation of breast tumors in transgenic mice, and COX-2 selective inhibitors can suppress tumorigenesis in rodent models of breast cancer.
15754118
2005
×
Entrez Id:
5743
Gene Symbol:
PTGS2
PTGS2
Mammary Neoplasms
0.400
Biomarker
LHGDN
Relationship between the expression of cyclooxygenase 2 and MDR1/P-glycoprotein in invasive breast cancers and their prognostic significance.
16168133
2005
×
Entrez Id:
5743
Gene Symbol:
PTGS2
PTGS2
Mammary Neoplasms
0.400
AlteredExpression
LHGDN
COX-2 overexpression increases motility and invasion of breast cancer cells.
15809733
2005
×
Entrez Id:
5743
Gene Symbol:
PTGS2
PTGS2
Mammary Neoplasms
0.400
AlteredExpression
LHGDN
Similarly, we identified vascular channels in high-grade invasive ductal carcinoma of the breast over-expressing COX-2 , but not in low-grade breast tumors .
17156488
2006
×
Entrez Id:
5743
Gene Symbol:
PTGS2
PTGS2
Mammary Neoplasms
0.400
AlteredExpression
LHGDN
Possible predictive markers related to micro-metastasis in breast cancer patients.
16596190
2006
×
Entrez Id:
5743
Gene Symbol:
PTGS2
PTGS2
Mammary Neoplasms
0.400
Biomarker
LHGDN
NFAT induces breast cancer cell invasion by promoting the induction of cyclooxygenase-2.
16505480
2006
×
Entrez Id:
5743
Gene Symbol:
PTGS2
PTGS2
Mammary Neoplasms
0.400
GeneticVariation
LHGDN
The cyclooxygenase-2 (PTGS2) 8473T>C polymorphism is associated with breast cancer risk.
16489098
2006
×
Entrez Id:
5743
Gene Symbol:
PTGS2
PTGS2
Mammary Neoplasms
0.400
Biomarker
LHGDN
Discoidin domain receptor 1 receptor tyrosine kinase induces cyclooxygenase-2 and promotes chemoresistance through nuclear factor-kappaB pathway activation.
16912190
2006
×
Entrez Id:
5743
Gene Symbol:
PTGS2
PTGS2
Mammary Neoplasms
0.400
Biomarker
LHGDN
Cyclooxygenase-2 uses the protein kinase C/ interleukin-8/urokinase-type plasminogen activator pathway to increase the invasiveness of breast cancer cells.
17332916
2007
×
Entrez Id:
5743
Gene Symbol:
PTGS2
PTGS2
Mammary Neoplasms
0.400
GeneticVariation
LHGDN
Functional polymorphisms in the cyclooxygenase 2 (COX-2) gene and risk of breast cancer in a Chinese population.
17479405
2007
×
Entrez Id:
5743
Gene Symbol:
PTGS2
PTGS2
Mammary Neoplasms
0.400
GeneticVariation
LHGDN
A polymorphism in the 3' untranslated region of the gene encoding prostaglandin endoperoxide synthase 2 is not associated with an increase in breast cancer risk: a nested case-control study.
17214885
2007
×
Entrez Id:
5743
Gene Symbol:
PTGS2
PTGS2
Mammary Neoplasms
0.400
AlteredExpression
LHGDN
COX-2 expression in lobular in situ neoplasia of the breast : correlation with histopathological grading system according to the Tavassoli classification.
17542993
2007
×
Entrez Id:
5743
Gene Symbol:
PTGS2
PTGS2
Mammary Neoplasms
0.400
AlteredExpression
LHGDN
Expression of cyclooxygenase-2 and 12-lipoxygenase in human breast cancer and their relationship with HER-2/neu and hormonal receptors: impact on prognosis and therapy.
17192687
2007
×
Entrez Id:
5743
Gene Symbol:
PTGS2
PTGS2
Mammary Neoplasms
0.400
AlteredExpression
LHGDN
Cyclooxygenase-2 expression during immortalization and breast cancer progression.
18199541
2008
×
Entrez Id:
5743
Gene Symbol:
PTGS2
PTGS2
Mammary Neoplasms
0.400
AlteredExpression
LHGDN
Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer.
18190720
2008
×
Entrez Id:
5743
Gene Symbol:
PTGS2
PTGS2
Mammary Neoplasms
0.400
Biomarker
LHGDN
The malignant phenotype of breast cancer cells is reduced by COX-2 silencing.
18953425
2008